These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 11260386

  • 21. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F, Morsing P, Paliege A, Ketteler M, Mayer B, Tapp R, Bachmann S.
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [Abstract] [Full Text] [Related]

  • 22. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
    Javkhedkar AA, Lokhandwala MF, Banday AA.
    Am J Physiol Renal Physiol; 2012 Jan 01; 302(1):F47-51. PubMed ID: 21900450
    [Abstract] [Full Text] [Related]

  • 23. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
    Zhao Y, Ma R, Yu X, Li N, Zhao X, Yu J.
    J Cardiovasc Pharmacol Ther; 2019 Sep 01; 24(5):450-459. PubMed ID: 31023080
    [Abstract] [Full Text] [Related]

  • 24. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA, Lokhandwala MF.
    Hypertension; 2008 Dec 01; 52(6):1099-105. PubMed ID: 18955661
    [Abstract] [Full Text] [Related]

  • 25. Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade.
    Zhou XJ, Vaziri ND, Zhang J, Wang HW, Wang XQ.
    Kidney Int; 2002 Sep 01; 62(3):914-21. PubMed ID: 12164873
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The angiotensin receptor antagonist 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV11974) attenuates the tubuloglomerular feedback response during NO synthase blockade in rats.
    Kawata T, Hashimoto S, Koike T.
    J Pharmacol Exp Ther; 1996 May 01; 277(2):572-7. PubMed ID: 8627533
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
    Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2003 Feb 01; 17(1):83-91. PubMed ID: 12588634
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.
    Nishimura Y, Xu T, Jöhren O, Häuser W, Saavedra JM.
    Basic Res Cardiol; 1998 Feb 01; 93 Suppl 2():63-8. PubMed ID: 9833166
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G, Simeoli R, Russo R, Santoro A, Pirozzi C, d'Emmanuele di Villa Bianca R, Mitidieri E, Paciello O, Pagano TB, Orefice NS, Meli R, Calignano A.
    Pharmacol Res; 2013 Oct 01; 76():67-76. PubMed ID: 23917217
    [Abstract] [Full Text] [Related]

  • 36. Impaired effect of nitric oxide synthesis inhibition on tubuloglomerular feedback in hypertensive rats.
    Thorup C, Persson AE.
    Am J Physiol; 1996 Aug 01; 271(2 Pt 2):F246-52. PubMed ID: 8770154
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Role of nitric oxide in impaired coronary circulation and improvement by angiotensin II receptor antagonist in spontaneously hypertensive rats.
    Fujita H, Takeda K, Nakamura K, Uchida A, Takenaka K, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 01; 22(1):S148-50. PubMed ID: 9072332
    [Abstract] [Full Text] [Related]

  • 40. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S, Iwao H.
    J Hypertens Suppl; 1997 Dec 01; 15(6):S3-7. PubMed ID: 9493120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.